LINAGLIPTIN N-BOC IMPURITY
UNII N3W7W93LXJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Linagliptin N-boc Impurity, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N3W7W93LXJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 668273-75-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

N3W7W93LXJ

CAS Registry Number

668273-75-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LINAGLIPTIN N-BOC IMPURITY

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C30H36N8O4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

PQEIZFATTRGTNW-HXUWFJFHSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

66754802

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1ccc2c(c1)nc(nc2C)Cn3c(n(c4c(c3=O)n(c(n4)N5C[C@@H](CCC5)NC(OC(C)(C)C)=O)CC#CC)C)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Linagliptin N-boc Impurity. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

LINAGLIPTIN N-BOC IMPURITY

Systematic Nomenclature

CARBAMIC ACID, N-((3R)-1-(7-(2-BUTYN-1-YL)-2,3,6,7-TETRAHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-2,6-DIOXO-1H-PURIN-8-YL)-3-PIPERIDINYL)-, 1,1-DIMETHYLETHYL ESTER

SYS

External Clinical & Regulatory Resources

Previous UNIIN3VZ68H2HY

Next UNIIN3W8UZM18I